Syndax Pharmaceuticals Inc — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Legault Pierre | — | Award / Grant | 16,000 | — | — | 48,000 | Feb 2, 2023 |
| Katkin Keith | — | Award / Grant | 16,000 | — | — | 48,000 | Feb 2, 2023 |
| Jarrett Jennifer | — | Award / Grant | 16,000 | — | — | 48,000 | Feb 2, 2023 |
| Ordentlich Peter | Chief Scientific Officer | Other | 69 | $17.32 | $1,195 | 69 | Feb 1, 2023 |
| Legault Pierre | — | Option Exercise | 5,000 | $13.58 | $67,900 | 37,000 | Jan 13, 2023 |
| Ordentlich Peter | Chief Scientific Officer | Sale | 3,772 | $25.01 | $94,338 | 265 | Dec 1, 2022 |
| Katkin Keith | — | Option Exercise | 20,782 | $7.88 | $163,762 | 52,782 | Oct 6, 2022 |
| Metzger Michael A | Chief Executive Officer | Option Exercise | 16,231 | $8.77 | $142,346 | 33,890 | Oct 6, 2022 |
| Metzger Michael A | Chief Executive Officer | Option Exercise | 2,883 | $8.77 | $25,284 | 20,542 | Oct 4, 2022 |
| Katkin Keith | — | Sale | 2,914 | $25.07 | $73,054 | 32,000 | Oct 4, 2022 |
| Morrison Briggs | President, Head of R&D | Option Exercise | 114,339 | $10.90 | $1,246,295 | 132,175 | Sep 19, 2022 |
| Morrison Briggs | President, Head of R&D | Option Exercise | 66,775 | $7.20 | $480,780 | 84,611 | Sep 16, 2022 |
| Podlesak Dennis | — | Option Exercise | 5,419 | $6.32 | $34,248 | 81,182 | Sep 16, 2022 |
| Legault Pierre | — | Sale | 14,000 | $23.02 | $322,280 | 32,000 | Aug 5, 2022 |
| Ordentlich Peter | Chief Scientific Officer | Sale | 22,846 | $25.04 | $572,064 | 265 | Jul 29, 2022 |
| Metzger Michael A | Chief Executive Officer | Option Exercise | 11,838 | $6.38 | $75,526 | 29,497 | Jul 25, 2022 |
| Metzger Michael A | Chief Executive Officer | Sale | 100 | $21.00 | $2,100 | 17,659 | Jul 6, 2022 |
| Morrison Briggs | President, Head of R&D | Sale | 62,292 | $19.00 | $1,183,548 | 17,836 | Jul 1, 2022 |
| Goldan Keith A. | Chief Financial Officer | Award / Grant | 3,205 | — | — | 3,205 | Jun 13, 2022 |
| Morrison Briggs | President, Head of R&D | Option Exercise | 70,545 | $7.20 | $507,924 | 88,381 | Apr 4, 2022 |
| Morrison Briggs | President, Head of R&D | Sale | 6,000 | $17.44 | $104,640 | 42,336 | Apr 4, 2022 |
| Podlesak Dennis | — | Award / Grant | 32,000 | — | — | 75,763 | Feb 2, 2022 |
| Katkin Keith | — | Award / Grant | 16,000 | — | — | 32,000 | Feb 2, 2022 |
| Legault Pierre | — | Award / Grant | 16,000 | — | — | 32,000 | Feb 2, 2022 |
| Egros Fabrice | — | Award / Grant | 16,000 | — | — | 32,000 | Feb 2, 2022 |
| Jarrett Jennifer | — | Award / Grant | 16,000 | — | — | 32,000 | Feb 2, 2022 |
| Meury William | — | Award / Grant | 16,000 | — | — | 32,000 | Feb 2, 2022 |
| Huber Martin H. Jr. | — | Award / Grant | 16,000 | — | — | 16,000 | Feb 2, 2022 |
| Ordentlich Peter | Chief Scientific Officer | Other | 1,412 | $12.39 | $17,495 | 1,412 | Feb 1, 2022 |
| Meyers Michael L. | SVP, Chief Medical Officer | Other | 1,714 | $12.39 | $21,236 | 23,280 | Jan 31, 2022 |
| Nolte Alexander | Chief Accounting Officer | Sale | 968 | $16.65 | $16,117 | — | Jan 31, 2022 |
| Meyers Michael L. | SVP, Chief Medical Officer | Option Exercise | 5,900 | $8.77 | $51,743 | 21,566 | Dec 30, 2021 |
| Legault Pierre | — | Option Exercise | 24,000 | $7.88 | $189,120 | 40,000 | Dec 20, 2021 |
| Morrison Briggs | Chief Executive Officer | Option Exercise | 35,156 | $10.90 | $383,200 | 83,492 | Dec 17, 2021 |
| Metzger Michael A | President and COO | Sale | 45,000 | $20.29 | $913,050 | 17,659 | Dec 16, 2021 |
| Metzger Michael A | President and COO | Sale | 2,045 | $19.05 | $38,957 | 17,659 | Dec 13, 2021 |
| Egros Fabrice | — | Option Exercise | 14,000 | $8.93 | $125,020 | 30,000 | Nov 18, 2021 |
| Metzger Michael A | President and COO | Sale | 44,704 | $19.13 | $855,188 | 17,659 | Oct 25, 2021 |
| Podlesak Dennis | — | Other | 463 | — | — | 43,763 | Oct 5, 2021 |
| Metzger Michael A | President and COO | Option Exercise | 24,437 | $7.20 | $175,946 | 42,096 | Sep 27, 2021 |
| Metzger Michael A | President and COO | Option Exercise | 300 | $7.20 | $2,160 | 17,959 | Sep 20, 2021 |
| Morrison Briggs | Chief Executive Officer | Option Exercise | 70,262 | $7.20 | $505,886 | 118,598 | Sep 20, 2021 |
| Metzger Michael A | President and COO | Sale | 16,651 | $19.02 | $316,702 | 17,659 | Sep 13, 2021 |
| Egros Fabrice | — | Option Exercise | 15,635 | $7.88 | $123,204 | 31,635 | Aug 18, 2021 |
| Egros Fabrice | — | Sale | 1,683 | $18.65 | $31,388 | 16,000 | May 18, 2021 |
| Meyers Michael L. | SVP, Chief Medical Officer | Purchase | 500 | $15.46 | $7,730 | 15,666 | Apr 26, 2021 |
| Podlesak Dennis | — | Purchase | 13,967 | $14.11 | $197,074 | 43,300 | Apr 22, 2021 |
| Egros Fabrice | — | Option Exercise | 10,167 | $6.35 | $64,560 | 26,167 | Mar 1, 2021 |
| Morrison Briggs | Chief Executive Officer | Sale | 35,156 | $20.55 | $722,456 | 48,336 | Feb 8, 2021 |
| Podlesak Dennis | — | Award / Grant | 29,333 | — | — | 29,333 | Feb 3, 2021 |